Skip to main content
. 2012 May 9;3(4):475–489. doi: 10.18632/oncotarget.479

Figure 2. SNF2L and SNF2LT expression by RT-PCR in different normal human tissues, cancers and cell lines.

Figure 2

A, expression of SNF2L and SNF2LT by RT-PCR in different human normal tissues. SNF2L was nearly ubiquitously expressed in human normal tissues with especially high expression in ovary and testis; SNF2LT was similarly expressed though only at a molar fraction of the level of SNF2L. B, both SNF2L as well as SNF2LT were expressed in all tested human cancer tissues. C, both SNF2L and SNF2LT were also expressed in nearly all human cancer cell lines with the exception of MARY-XT (xenograft tumor) and in vitro derived spheroids (MARY-X SP), both derived from a patient with inflammatory breast cancer (26,27). ACTB served as housekeeping control. Each experiment was performed in triplicate and repeated at least four times.